Analyst firms · UBS · ISRG

UBS ISRG price target and rating history

Intuitive Surgical Inc. (ISRG) · Health Care

UBS rates Intuitive Surgical Inc. (ISRG) Buy with a $500 price target, as of its latest action on Jul 28, 2026. It has published 5 rating actions on ISRG since July 2021, including 1 upgrade and 0 downgrades. Across 7 firms with a ISRG price target in the last 12 months, the median target is $500. UBS's target matches it.

Current rating

Buy

Price target

$500

Median target, all firms

$500

Actions on ISRG

5

UBS price target on ISRG

Every UBS rating on ISRG

• Jul 28, 2026
  InitiateUBS starts coverage at Buy, price target $500
• Mar 29, 2023
  InitiateUBS starts coverage at Neutral, price target $278
• Feb 2, 2022
  UpgradeUBS upgrades to Buy from Neutral, price target $317 to $325
• Jan 21, 2022
  ReiterateUBS cuts its price target to $317 from $338, keeps Neutral
• Jul 21, 2021
  ReiterateUBS raises its price target to $970 from $890, keeps Neutral

How other firms rate ISRG

Each firm's latest rating and stated target in the last 12 months.

Questions about UBS and ISRG

What is UBS's price target for ISRG?

UBS's latest stated price target for Intuitive Surgical Inc. (ISRG) is $500, from its action on Jul 28, 2026.

What is UBS's rating on ISRG?

UBS rates ISRG Buy, a bullish rating, as of Jul 28, 2026.

When did UBS last change its view on ISRG?

On Jul 28, 2026, UBS starts coverage at Buy, price target $500.

How does UBS's ISRG target compare with other analysts?

Across 7 firms with a ISRG price target in the last 12 months, the median target is $500. UBS's target matches it.

More ISRG rating histories

• Erste Group3
• Citigroup7
• Deutsche Bank3
• Morgan Stanley7
• Evercore ISI3
• BTIG3
• Stifel4
• Wells Fargo4
• BofA Securities3
• Piper Sandler3

All UBS ratingsISRG news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.